
Sasan Mirfakhraee MD
Diabetes, Lipid Metabolism
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center
Join to View Full Profile
- 5323 Harry Hines BlvdDallas, TX 75390 
- Phone+1 214-645-2800 
- Fax+1 214-645-2808 
Dr. Mirfakhraee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013 University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013
 University of ColoradoResidency, Internal Medicine, 2006 - 2009 University of ColoradoResidency, Internal Medicine, 2006 - 2009
 LSU School of Medicine in ShreveportClass of 2006 LSU School of Medicine in ShreveportClass of 2006
Certifications & Licensure
 TX State Medical License 2009 - 2027 TX State Medical License 2009 - 2027
 CO State Medical License 2006 - 2009 CO State Medical License 2006 - 2009
 American Board of Internal Medicine Endocrinology, Diabetes and Metabolism American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index.Andrew Horvit, Katie Kaput, Amber Neece, Jessica Abramowitz, Marconi Abreu
 Journal of Cystic Fibrosis. 2025-10-17
- Cortisol Testing to Diagnose Adrenal Insufficiency Following Adrenalectomy for Mild Autonomous Cortisol Secretion.Oksana Hamidi, Bahaa Salama, Tracy Wang, James W Findling, Catherine D Zhang
 The Journal of Clinical Endocrinology and Metabolism. 2025-09-12
- Differences in α-Blockade Practices Between Endocrine and Surgical Specialties for Pheochromocytoma and Paraganglioma Resection: A Single-Center Retrospective Study.Jorge E Mosquera, Shubham Agarwal, Megan Maxwell, Trent Bryson, Mishal Johny
 Endocrine Practice. 2025-09-12
Press Mentions
 Clinical Experience with Intravenous Zoledronic Acid in the Treatment of Male Osteoporosis: Evidence and OpinionsAugust 1st, 2013 Clinical Experience with Intravenous Zoledronic Acid in the Treatment of Male Osteoporosis: Evidence and OpinionsAugust 1st, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









